Your Heart Isn't Speeding Up During Exercise. Here's Why.

NOS3 is the enzyme that produces nitric oxide in your blood vessel walls. Nitric oxide is the molecule that tells your blood vessels to relax and dilate. When you exercise, your body needs to deliver more oxygen to your muscles. Nitric oxide is how that happens. Without it, your vessels stay rigid, your muscles don’t get the blood flow they need, and your heart has to work much harder to try to compensate.

The Glu298Asp variant in NOS3 is common, carried by roughly 30-40% of the population. This variant reduces your cells’ ability to produce nitric oxide by up to 50%. Your blood vessels literally cannot relax and expand the way they should, even when your body is screaming for more blood flow.

This manifests as a sluggish heart rate response during exercise, rapid fatigue, and a sensation that your heart is working overtime but going nowhere. You might also experience elevated blood pressure at rest, since your vessels are chronically constricted.

ACE is responsible for converting a hormone called angiotensin I into angiotensin II, which constricts blood vessels and raises blood pressure. Your body needs this system for blood pressure regulation, but it needs to be balanced. When ACE activity is too high, your vessels stay constricted, your blood pressure climbs, and your heart works harder than it should at rest and during stress.

The ACE I/D (insertion/deletion) polymorphism determines how much ACE enzyme you produce. The D/D homozygous genotype, present in roughly 25% of the population, is associated with higher ACE activity. Higher ACE activity means your blood vessels constrict more aggressively, your resting blood pressure is elevated, and your heart has less room to accelerate during exercise because it’s already running at a higher baseline.

You experience this as an inability to achieve a normal heart rate response, often paired with hypertension or prehypertension. Your heart rate might increase, but not as much as it should relative to your workload. You might also experience premature fatigue during exercise.

MTHFR is an enzyme that converts dietary folate into its active form, methylfolate. This active form fuels your methylation cycle, which is responsible for producing neurotransmitters, regulating inflammation, and controlling homocysteine levels. Homocysteine is an amino acid; in excess, it damages blood vessel walls and increases cardiovascular risk dramatically.

The C677T variant of MTHFR, carried by roughly 40% of the population, reduces the enzyme’s efficiency by 40-70%. You can eat a diet rich in folate and still accumulate homocysteine because your cells cannot convert the folate into its usable form. Elevated homocysteine is an independent cardiovascular risk factor that damages your endothelium, the critical lining of your blood vessels.

With elevated homocysteine, your blood vessels become inflamed and stiff. They cannot dilate properly in response to exercise. Your heart rate might not climb because the vascular system itself is compromised, unable to accommodate the increased demand for blood flow. You may also experience arrhythmias or irregular heartbeats during stress.

COMT is the enzyme that breaks down dopamine, norepinephrine, and epinephrine, the three stress hormones. These hormones are what tell your heart to accelerate during exercise. Your body produces them on demand, and COMT clears them when they’re no longer needed. If COMT is slow, these hormones linger in your system. If COMT is fast, you clear them too quickly.

The Val158Met variant determines your COMT activity. The Met/Met genotype, present in roughly 25% of the European population, produces a slow-acting COMT enzyme. Slow COMT means stress hormones linger in your bloodstream long after the stressor is gone, creating a state of chronically elevated sympathetic activation. Your nervous system feels flooded with adrenaline even at rest.

Here’s the paradox: even though your stress hormones are elevated, they’re not producing an appropriate heart rate response during exercise. This is because your system is already saturated; you’ve lost sensitivity to the signal. You might feel anxious and wired at rest, but during exercise, your heart rate barely moves. You’re also more prone to anxiety, emotional reactivity, and difficulty recovering after stress.

SCN5A encodes the primary sodium channel in your heart’s conduction system. This channel is responsible for generating and propagating the electrical signals that make your heart beat. Every heartbeat starts with a carefully timed electrical impulse. Your heart’s pacemaker cells use sodium channels to fire that impulse. If these channels are compromised, the electrical signal either fires too slowly or doesn’t propagate correctly through the heart muscle.

Variants in SCN5A can impair channel function, resulting in slower electrical conduction and delayed heart rate acceleration. The exact prevalence depends on the specific variant, but loss-of-function variants in SCN5A are associated with congenital long QT syndrome and Brugada syndrome, both of which impair the electrical system’s ability to respond to demands. Your pacemaker cells simply cannot fire fast enough when your body needs more blood flow, leaving your heart rate chronotropically incompetent.

You experience this as a profound inability to accelerate your heart rate during exercise, sometimes paired with palpitations, lightheadedness, or a sensation that your heart is skipping or stuttering. The problem is purely electrical, not mechanical.

KCNQ1 encodes a potassium channel critical for repolarization, the process by which your heart muscle cells reset after each contraction, preparing for the next beat. These potassium channels are also involved in the autonomic nervous system’s ability to signal your heart to accelerate. If these channels don’t function properly, repolarization is delayed, and the autonomic signal to increase heart rate is muted.

Variants in KCNQ1 are associated with long QT syndrome, a condition in which the electrical recovery phase of the heartbeat is prolonged. This increases arrhythmia risk and impairs the heart’s ability to increase its rate appropriately. Even with maximum sympathetic drive, your heart’s electrical system cannot fire fast enough to match your body’s metabolic demand. The potassium channel simply will not allow it.

You experience complete chronotropic incompetence, often with a heart rate that barely increases even during maximal exertion. You may also have a prolonged QT interval on an ECG, palpitations, syncope (fainting), or seizures during exertion.